NTHI News

Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include one larger recent filer, skilled nursing care provider PACS Group (PACS). A few other sizable IPOs in...read more

No IPOs debuted this past, as two companies previously scheduled to list (NTHI and RAN) kicked the can down the road. Seven IPOs and one SPAC submitted initial filings this week. Meanwhile, social media platform Reddit (RDDT) launched its $715 million IPO, and Peru-based healthcare firm Auna (AUNA) launched its $420 million IPO. Both are...read more

Two listings are currently scheduled for the week ahead, although one is excluded from our IPO stats. Other issuers may join the calendar throughout the week. Phase 2 brain cancer biotech NeOnc Technologies (NTHI) plans to raise $75 million at a $315 million market cap. Its most advanced candidate, NEO100, is a purified form of perillyl acid which is administered...read more

NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, revised the terms for its upcoming IPO on Friday. The Westlake Village, CA-based company now plans to raise $75 million by offering 6 million shares at a price range of $11.25 to $13.75. The company had previously filed to offer 3.8 million shares at a range of $18.75 to $20.75...read more